PLUS1
77.2
0.25 (0.32%)
0.25 (0.32%)
Upgrade to Real-Time
Premarket
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Merck and Co Inc | MRK | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 76.95 | 0.00 | 0.00 | 0.00 | 76.95 | 06:40:26 |
| Stock Trades | Traded Volume | Average Volume | 52 Week Range |
|---|---|---|---|
| 6 | 160 | 16,275,527 | 65.25 - 92.64 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 06:16:37 | 50 | $ 77.20 | USD |
Merck Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 195.17B | 2.54B | $ 6.22B | 3.81 | 19.30 | 2.53B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 18.16M | $ 2.26 | 2.94% | 03/13/20 | - | - |
Merck News
| Date | Time | Source | News Article |
|---|---|---|---|
| 3/28/2020 | 10:00 | Business Wire | Investigational Drug Vericiguat Significantly Reduced the.. |
| 3/25/2020 | 17:00 | Business Wire | Merck to Donate 300,000 Masks to New Jersey for COVID-19.. |
| 3/23/2020 | 06:32 | Dow Jones News | Merck Donates Half a Million Protective Masks to New York.. |
| 3/22/2020 | 11:52 | Business Wire | Merck Donates a Half a Million Masks to Support COVID-19.. |
| 3/20/2020 | 17:01 | Business Wire | Merck Recommends Rejection of TRC Capital’s “Mini-Tender”.. |
| 3/18/2020 | 17:26 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/18/2020 | 17:25 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MRK Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 68.93 | 77.59 | 66.75 | 71.04 | 16,347,698 | 8.02 | 11.63% |
| 1 Month | 81.96 | 83.07 | 65.25 | 74.08 | 17,966,451 | -5.01 | -6.11% |
| 3 Months | 90.81 | 92.0554 | 65.25 | 80.14 | 14,048,553 | -13.86 | -15.26% |
| 6 Months | 83.2135 | 92.64 | 65.25 | 82.48 | 10,589,164 | -6.26 | -7.53% |
| 1 Year | 83.72 | 92.64 | 65.25 | 82.12 | 10,263,693 | -6.77 | -8.09% |
| 3 Years | 63.26 | 92.64 | 52.83 | 70.89 | 9,969,757 | 13.69 | 21.64% |
| 5 Years | 58.19 | 92.64 | 45.69 | 65.65 | 9,716,769 | 18.76 | 32.24% |
Merck Description
| Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiovascular disease, asthma, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, close to 40% of the firm's sales are generated in the United States. |
